Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 16, 2022
Could a prostate cancer drug save lives from radiation injury?
Early research shows potential for approved hormone-blocking drug to protect from deadly effects of nuclear blast
Dr. Hans-Peter Kiem
<p>'He really wanted to fight this cancer': A stem cell researcher remembers his first patient in a gene therapy clinical trial
Dramatic remissions seen in immunotherapy trial of blood cancer patients
Experimental, living T-cell therapy shows promise for treating advanced disease, making immunotherapy a ‘pillar’ of cancer care
Study sheds new light on molecular pathways behind marrow disorders
How a single alteration in fundamental cellular machinery drives blood diseases and cancers
‘The successes kept you going’: 40 years of bone marrow transplantation
On the eve of ‘Emperor’ cancer documentary, Dr. Fred Appelbaum recounts 40 years of difficult and exhilarating advances in bone marrow transplantation
Beyond blood drives: Stem cell donors help fuel scientific discovery
Volunteers for the little-known procedures earn up to $800 – and the chance to contribute to cutting-edge research
Transplanted stem cell 'shield' helps brain cancer patients
Hans-Peter Kiem study is first to show patients' own gene-modified blood stem cells can protect bone marrow from chemotherapy toxicity
Transplanted gene-modified blood stem cells protect brain cancer patients from toxic side effects of chemotherapy
Study is first to show feasibility and efficacy of a new use for autologous stem cell transplant
Clinical researchers win pediatric oncology awards
Colleen Delaney, Akiko Shimamura receive grants totaling $600,000 from St. Baldrick’s Foundation
Modified marrow cells may resist chemotherapy’s toxic effects
Hans-Peter Kiem and colleagues find chemo-resistant genes may enable safer, more effective treatment for brain cancer patients
For the First Time a Molecular Test Proves to be Effective in Measuring the Extent of Remission After Cancer Treatment and the Potential for Relapse
The molecular test is already saving lives of patients who relapse after bone-marrow or stem-cell transplantation. Researchers now predict that the approach will speed the delivery of promising new therapies to other patients
Study Raises Doubt About the Notion of Adult Stem Cell Plasticity
Adult stem cells from bone marrow fail to generate stromal cells after hematopoietic cell transplantation